Sunnybrook Health Sciences Centre

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1948-01-01

Employees: 10K

Market Cap: -

Website: http://www.sunnybrook.ca

Clinical Trials

Recovery Improved in Covert Stroke With Exercise

Not Applicable

Completed

Conditions: Cerebral Small Vessel Diseases

Interventions: Behavioral: Stretching Program
Behavioral: Exercise Program

First Posted Date: 2014-02-21

Last Posted Date: 2018-09-18

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 39

Registration Number: NCT02068391

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)

Phase 2

Terminated

Conditions: Myelodysplastic Syndromes

Interventions: Drug: Deferasirox + Azacitidine
Drug: Azacitidine

First Posted Date: 2014-01-17

Last Posted Date: 2018-04-26

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 1

Registration Number: NCT02038816

Locations: 🇨🇦
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

The Impact of a Patient Education Intervention for Ambulatory Oncology Patients

Not Applicable

Completed

Conditions: Lung Cancer
Gastro-intestinal Cancer
Head and Neck Cancer
Breast Cancer

Interventions: Behavioral: Instructed to read patient education pamphlets

First Posted Date: 2014-01-16

Last Posted Date: 2014-09-08

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 96

Registration Number: NCT02038114

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer

Phase 2

Conditions: Prostate Cancer

Interventions: Dietary Supplement: Capsaicin Supplement (Cayenne by Nature's Way)

First Posted Date: 2014-01-16

Last Posted Date: 2014-01-16

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 100

Registration Number: NCT02037464

Locations: 🇨🇦
Sunnybrook Hospital, Toronto, Ontario, Canada

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

Phase 3

Completed

Conditions: Alzheimer's Disease
Dementia

Interventions: Drug: Cholinesterase Inhibitor
Drug: Placebo

First Posted Date: 2014-01-14

Last Posted Date: 2017-04-28

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 40

Registration Number: NCT02035982

Locations: 🇨🇦
North York General Hospital, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial

Not Applicable

Conditions: Cancer
Metastases
Liver Neoplasms

Interventions: Other: Liver MRI with Gdfos
Other: Liver MRI with EcGd

First Posted Date: 2014-01-14

Last Posted Date: 2014-01-14

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 150

Registration Number: NCT02036008

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Vemurafenib
Drug: Cobimetinib

First Posted Date: 2014-01-14

Last Posted Date: 2022-10-27

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 24

Registration Number: NCT02036086

Locations: 🇨🇦
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
🇨🇦
Royal Victoria Hospital, Montreal, Quebec, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Driving in Mild Dementia Decision Tool

Not Applicable

Completed

Conditions: Dementia

Interventions: Other: Driving in Mild Dementia Decision Tool

First Posted Date: 2014-01-14

Last Posted Date: 2021-02-10

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 69

Registration Number: NCT02036099

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer

Phase 1

Active, not recruiting

Conditions: Prostate Adenocarcinoma

Interventions: Radiation: Stereotactic Ablative Radiation

First Posted Date: 2014-01-09

Last Posted Date: 2020-11-24

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 30

Registration Number: NCT02031328

Locations: 🇨🇦
Sunnybrook Health Science Centre Odette Cancer Centre, Toronto, Ontario, Canada

Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib

Phase 2

Completed

Conditions: Clear Cell Metastatic Renal Cell Carcinoma

Interventions: Radiation: Stereotactic radiotherapy

First Posted Date: 2013-12-24

Last Posted Date: 2021-03-23

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 38

Registration Number: NCT02019576

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy